{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:07:49Z","timestamp":1790676469107,"version":"4.1.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006439","name":"Faculty of Tropical Medicine, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The emergence of artemisinin resistance is a major obstacle to the global malaria eradication\/elimination programs. Artemisinin is a very fast-acting antimalarial drug and is the most important drug in the treatment of severe and uncomplicated malaria. For the treatment of acute uncomplicated falciparum malaria, artemisinin derivatives are combined with long half-life partner drugs and widely used as artemisinin-based combination therapies (ACTs). Some ACTs have shown decreased efficacy in the Southeast Asian region. Fortunately, artemisinin has an excellent safety profile and resistant infections can still be treated successfully by modifying the ACT. This review describes the pharmacological properties of ACTs, mechanisms of artemisinin resistance and the potential changes needed in the treatment regimens to overcome resistance. The suggested ACT modifications are extension of the duration of the ACT course, alternating use of different ACT regimens, and addition of another antimalarial drug to the standard ACTs (Triple-ACT). Furthermore, a malaria vaccine (e.g., RTS,S vaccine) could be added to mass drug administration (MDA) campaigns to enhance the treatment efficacy and to prevent further artemisinin resistance development. This review concludes that artemisinin remains the most important antimalarial drug, despite the development of drug-resistant falciparum malaria.<\/jats:p>","DOI":"10.3389\/fphar.2022.876282","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T06:42:02Z","timestamp":1663915322000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Artemisinin resistance and malaria elimination: Where are we now?"],"prefix":"10.3389","volume":"13","author":[{"given":"Borimas","family":"Hanboonkunupakarn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasithon","family":"Pukrittayakamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesinee","family":"Chotivanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS, S\/AS01 malaria vaccine in african infants","volume":"367","author":"Agnandji","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: A multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: A genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.1615875114","article-title":"Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort","volume":"114","author":"Ataide","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood-2017-11-814665","article-title":"Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance","volume":"131","author":"Bhattacharjee","year":"2018","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/CMR.00051-10","article-title":"Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination","volume":"24","author":"Bousema","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/s0140-6736(79)92383-3","article-title":"Chloroquine-resistant Plasmodium falciparum from east Africa: Cultivation and drug sensitivity of the Tanzanian I\/CDC strain from an American tourist","volume":"2","author":"Campbell","year":"1979","journal-title":"Lancet (London, Engl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00101","DOI":"10.1128\/AAC.00101-19","article-title":"Decreased in vitro artemisinin sensitivity of Plasmodium falciparum across India","volume":"63","author":"Chakrabarti","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Chhibber-Goel","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1128\/AAC.01924-13","article-title":"Laboratory detection of artemisinin-resistant Plasmodium falciparum","volume":"58","author":"Chotivanich","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-019-08297-9","article-title":"Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children","volume":"10","author":"Chotsiri","year":"2019","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/cid\/cis958","article-title":"Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria","volume":"56","author":"Das","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9946","DOI":"10.1038\/s41598-021-89295-0","article-title":"Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India","volume":"11","author":"Das","year":"2021","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/ciy1038","article-title":"Novel pfkelch13 gene polymorphism associates with artemisinin resistance in Eastern India","volume":"69","author":"Das","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12936-020-3139-6","article-title":"The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput","volume":"19","author":"Davis","year":"2020","journal-title":"Malar. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","article-title":"Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0035-9203(79)90220-7","article-title":"Chloroquine-resistant Plasmodium falciparum malaria in Kenya","volume":"73","author":"Fogh","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00060","DOI":"10.1128\/AAC.00060-19","article-title":"Sequential open-Label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults","volume":"63","author":"Hanboonkunupakarn","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","first-page":"148","article-title":"Chloroquine resistance in Plasmodium falciparum in Thailand","author":"Harinasuta","year":"1962"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1002212","DOI":"10.1371\/journal.pmed.1002212","article-title":"Population pharmacokinetic properties of piperaquine in falciparum malaria: An individual participant data meta-analysis","volume":"14","author":"Hoglund","year":"2017","journal-title":"PLoS Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the greater Mekong subregion: An observational study","volume":"20","author":"Imwong","year":"2020","journal-title":"Lancet. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/infdis\/jiy673","article-title":"Tracking Resistance to Artemisinin CollaborationArtemisinin resistance and stage dependency of parasite clearance in falciparum malaria","volume":"219","author":"Intharabut","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4269\/ajtmh.2005.73.222","article-title":"Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection","volume":"73","author":"John","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/526787","article-title":"Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children","volume":"197","author":"John","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","article-title":"Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: A systematic review and spatiotemporal analysis","volume":"3","author":"Kagoro","year":"2022","journal-title":"Lancet. Microbe"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1128\/AAC.00482-15","article-title":"Altering antimalarial drug regimens may dramatically enhance and restore drug effectiveness","volume":"59","author":"Kay","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bcp.12660","article-title":"Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation","volume":"80","author":"Kloprogge","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi","volume":"355","author":"Laufer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1475-2875-12-343","article-title":"Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia","volume":"12","author":"Leang","year":"2013","journal-title":"Malar. J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","article-title":"Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: Dihydroartemisinin-piperaquine open-label multicenter clinical assessment","volume":"59","author":"Leang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","article-title":"Immune effector mechanisms in malaria","volume":"28","author":"Marsh","year":"2006","journal-title":"Parasite Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0264339","DOI":"10.1371\/journal.pone.0264339","article-title":"Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-saharan Africa: A systematic review and meta-analysis","volume":"17","author":"Marwa","year":"2022","journal-title":"PloS one"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/jac\/dkab264","article-title":"Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries","volume":"76","author":"Mathieu","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1009133","DOI":"10.1371\/journal.ppat.1009133","article-title":"Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea","volume":"16","author":"Miotto","year":"2020","journal-title":"PLoS Pathog."},{"key":"B43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1475-2875-13-284","article-title":"Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India","volume":"13","author":"Mishra","year":"2014","journal-title":"Malar. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.1961.10.5","article-title":"Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine","volume":"10","author":"Moore","year":"1961","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1007\/BF02561666","article-title":"Combination therapy as a tool to prevent emergence of bacterial resistance","volume":"27","author":"Mouton","year":"1999","journal-title":"Infection"},{"key":"B47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12936-017-1845-5","article-title":"Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia","volume":"16","author":"Mukherjee","year":"2017","journal-title":"Malar. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e01140","DOI":"10.1128\/AAC.01140-19","article-title":"A randomized controlled trial of three- versus five-day artemether-lumefantrine regimens for treatment of uncomplicated Plasmodium falciparum malaria in pregnancy in Africa","volume":"64","author":"Onyamboko","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/infdis\/jiaa562","article-title":"Dormant Plasmodium falciparum parasites in human infections following artesunate therapy","volume":"223","author":"Peatey","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(21)00692-7","article-title":"Triple therapy with artemether\u2013lumefantrine plus amodiaquine versus artemether\u2013lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: An open-label, randomised, multicentre trial","volume":"22","author":"Peto","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"CD008846","DOI":"10.1002\/14651858.CD008846.pub2","article-title":"Mass drug administration for malaria","volume":"2013","author":"Poirot","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/nm.4426","article-title":"Rationalizing combination therapies","volume":"23","author":"Author Anonymous","year":"2017","journal-title":"Nat. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1006930","DOI":"10.1371\/journal.ppat.1006930","article-title":"Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites","volume":"14","author":"Rocamora","year":"2018","journal-title":"PLoS Pathog."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2875-8-10","article-title":"Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia","volume":"8","author":"Rogers","year":"2009","journal-title":"Malar. J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1073\/pnas.1813386115","article-title":"Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model","volume":"115","author":"S\u00e1","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12916-021-02002-8","article-title":"A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border","volume":"19","author":"Saito","year":"2021","journal-title":"BMC Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1073\/pnas.1006113108","article-title":"Intrahost modeling of artemisinin resistance in Plasmodium falciparum","volume":"108","author":"Saralamba","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e01134","DOI":"10.1128\/mBio.01134-19","article-title":"Role of Plasmodium falciparum Kelch 13 protein mutations in P. falciparum populations from Northeastern Myanmar in mediating artemisinin resistance","volume":"11","author":"Siddiqui","year":"2020","journal-title":"mBio"},{"key":"B61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coph.2018.06.003","article-title":"Mechanisms of artemisinin resistance in Plasmodium falciparum malaria","volume":"42","author":"Suresh","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1475-2875-11-293","article-title":"Population pharmacokinetics of artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda","volume":"11","author":"Tarning","year":"2012","journal-title":"Malar. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1128\/AAC.00195-09","article-title":"Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria","volume":"53","author":"Tarning","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: Duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e01578","DOI":"10.1128\/AAC.01578-16","article-title":"K13 propeller mutations in Plasmodium falciparum populations in regions of malaria endemicity in Vietnam from 2009 to 2016","volume":"61","author":"Thuy-Nhien","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B66","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum.","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12936-018-2404-4","article-title":"Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar","volume":"17","author":"Tun","year":"2018","journal-title":"Malar. J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12936-017-2130-3","article-title":"Towards malaria elimination in savannakhet, Lao PDR: Mathematical modelling driven strategy design","volume":"16","author":"Tun","year":"2017","journal-title":"Malar. J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: An open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet. Infect. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: A prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet. Infect. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: A multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/21645515.2019.1643675","article-title":"Combining antimalarial drugs and vaccine for malaria elimination campaigns: A randomized safety and immunogenicity trial of RTS, S\/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers","volume":"16","author":"von Seidlein","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","article-title":"The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial","volume":"16","author":"von Seidlein","year":"2019","journal-title":"PLoS Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e02499","DOI":"10.1128\/AAC.02499-16","article-title":"Impact of extended duration of artesunate treatment on parasitological outcome in a cytocidal murine malaria model","volume":"61","author":"Walker","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12936-018-2396-0","article-title":"Introduction of F446I mutation in the K13 propeller gene leads to increased ring survival rates in Plasmodium falciparum isolates","volume":"17","author":"Wang","year":"2018","journal-title":"Malar. J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1128\/AAC.01255-15","article-title":"Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1008577","DOI":"10.1371\/journal.pcbi.1008577","article-title":"Immune selection suppresses the emergence of drug resistance in malaria parasites but facilitates its spread","volume":"17","author":"Whitlock","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: In-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"","journal-title":"Lancet. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: A phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia","volume":"57","author":"Witkowski","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature00813","article-title":"Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum","volume":"418","author":"Wootton","year":"2002","journal-title":"Nature"},{"key":"B84","volume-title":"Mass drug administration, mass screening and treatment and focal screening and treatment for malaria","year":"2015"},{"key":"B85","volume-title":"World malaria report 2021","year":"2021"},{"key":"B86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpddr.2019.04.002","article-title":"In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations","volume":"10","author":"Zhang","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B87","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42003-022-03215-0","article-title":"Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response","volume":"5","author":"Zhu","year":"2022","journal-title":"Commun. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.876282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T06:42:15Z","timestamp":1663915335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.876282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":87,"alternative-id":["10.3389\/fphar.2022.876282"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.876282","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"876282"}}